Interview with Richard Calder, the President and CEO of GTT Communications, Inc. ($GTT), from The Wall Street Transcript. twst.com/interview/interview… #stocks #investing #it #itservices #software #nyse

Interview with the CEO and Chairman of Perficient, Inc. ($PRFT), Jeffrey Davis, from The Wall Street Transcript. twst.com/interview/interview… #stocks #investing #it #itservices #software #nasdaq

Senior Analyst at Needham & Company discusses how consistent growth will continue in the enterprise software space in an interview with The Wall Street Transcript. twst.com/interview/consisten… #stocks #investing #it #itservices #software

Interview with Peter Dameris, CEO of ASGN Incorporated ($ASGN), from The Wall Street Transcript. twst.com/interview/interview… #stocks #investing #it #itservices #software #nyse

VP at Piper Jaffray, Jason Deleeuw, discusses the importance of collaboration and a business use case needed to move to blockchain in an interview with The Wall Street Transcript. twst.com/interview/collabora… #stocks #investing #it #itservices #software #blockchain

Interview with the CEO of StrikeForce Technologies, Inc. ($SFOR), Mark Kay, from The Wall Street Transcript. twst.com/interview/interview… #stocks #investing #it #itservices #software

Interview with Rollie Johns, the EVP and CFO of CSG Systems International, Inc. ($CSGS) from The Wall Street Transcript. twst.com/interview/interview… #stocks #investing #it #itservices #software

Founder and Director of Research at Standpoint Research, Ronnie Moas, expects cryptocurrency to go mainstream as the eighth asset class in an interview with The Wall Street Transcript. twst.com/interview/expecting… #stocks #investing #cryptocurrency

New report on IT Services and Software with 10 exclusive executive and analyst interviews from The Wall Street Transcript. twst.com/report/it-services-… #stocks #investing #it #itservices #software

Portfolio Manager at Dana Investment Advisors on bringing expertise, longevity and advocacy to ESG investing in an interview with The Wall Street Transcript. twst.com/interview/bringing-… #stocks #investing

Founder and Chairman of Monetta Financial Services, Inc., Robert Bacarella, talks about providing diversification and an opportunity to exceed market returns in an interview with The Wall Street Transcript. twst.com/interview/providing… #stocks #investing

Robert Marren, Portfolio Manager and Managing Director with Allianz Global Investors, on finding opportunities in small-cap growth as experts in change. twst.com/interview/finding-o… #stocks #investing

New report on Investing Strategies featuring three exclusive analyst interviews from The Wall Street Transcript. twst.com/report/investing-st… #stocks #investing

Boston Private Manager/Director Nancy Perez talks about looking for stocks that both pay and grow dividends with The Wall Street Transcript. twst.com/interview/looking-f… #stocks #investing

Principal of Luther King Capital Management, Paul Greenwell, discusses investing long term in the best-positioned companies with The Wall Street Transcript. twst.com/interview/investing… #stocks #investing

Robert Henderson, Portfolio Manager at RBC Global Asset Management, on buying competitively advantaged companies in the midcap space. twst.com/interview/buying-co… #stocks #investing

New report on Investing Strategies from The Wall Street Transcript with four new exclusive analyst interviews. twst.com/report/investing-st… #stocks #investing

Interview with the CEO and Managing Director of Mesoblast Limited ($MESO), Silviu Itescu, from The Wall Street Transcript. twst.com/interview/interview… #stocks #investing #biotechnology #pharma #nasdaq

Kumaraguru Raja at Brookline Capital Markets tells The Wall Street Transcript that early-stage biotechs to release clinical data readouts in 2019 twst.com/interview/early-sta… #stocks #investing #biotechnology #pharma

Managing Partner and President of WBB Securities, Steve Brozak, talks to The Wall Street Transcript on the scrutiny of pharmacy benefit managers resulting in visibility of drug prices. twst.com/interview/scrutiny-… #stocks #investing #biotechnology #pharma